- Patients Own Drugs - Missed Doses - Anticoagulants - Medication Safety Officer role
|
|
|
- Roberta Wilkinson
- 6 years ago
- Views:
Transcription
1 EAHP ACADEMY SEMINAR 30 Sept - 1 Oct 2016, Bucharest From Medicines Reconciliation to Medicines Optimisation - Patients Own Drugs - Missed Doses - Anticoagulants - Medication Safety Officer role Jane Smith, Principal Pharmacist, Development & Governance NBT Medication Safety Officer (MSO) (UK)
2 Disclosure Statement "Conflict of interest: nothing to disclose"
3 Learning Objectives Participants should be able to: Transfer principles of the use of Patients Own Drugs Understand how to measure and highlight the issue of Missed Doses Understand how to measure and Reducing Harm from Anticoagulants Understand the role of the Medication Safety Officer (in England) and what principles can be transferred for local use in improving reporting of and reducing harm from incidences
4 SUMMARY QUESTIONS: Linked with the learning Objectives for today: Missed Doses impact on the outcome of Medicines Reconciliation and Medication review. True or false? Patients Own Drugs (in the UK) are a useful source for aiding Medicines Reconciliation and Medication review. True or false? The incidence of high INRs do not impact on Medication review. True or false?
5 Who are we? NBT North Bristol Patient Safety: Medicines Management work stream
6 North Bristol NHS Trust (NBT) All of our work started on: Acute Teaching Trust: 2 sites 1087 beds 53 wards 9100 staff Safer Patients Initiative (SPI2): Southwest Quality and Patient Safety Improvement programme: End of May 2014: New Hospital: Now approx. 850 beds and 27 ward areas
7 NBT Team Medicines Governance Group Director of Pharmacy Pharmacists Matrons Heads of Nursing Consultants Training Dept Patient Panel Members Executive Lead: Medical Director Chris Burton Pharmacy Jane Smith Alison Mundell Julie Hamer Natasha Mogford Robert Brown Clinical Audit Frank Hamill Calvin Turp Rebecca Lewis Nurses Lorraine Motuel Andrea Scott Consultants / Doctors Arla Gamper Ruth Gillam James Calvert
8 Quality Improvement Methodology Ongoing measurement Tests of change
9 Patients Own Drugs (PODs) key drivers: PODs are the medicines that a patient has been taking before admission to hospital and can include Rx medicines, herbal, Over-the-counter etc. Duthie report (1988) A Spoonful of Sugar (2001) Improving the use of medicines for better outcomes and reduced waste: An Action Plan (2012)
10 Patients Own Drugs actions: Phase 1: : Pharmacy based: Phase 2: : Ward based: Phase 3: : Medicines Management: trials: Phase 4: : MM: service spread MM Technicians are trained in all aspects of the process: Patients/Carers interviewed about PODs and PODs at home Depending on the estimated LOS - PODs are used on ward and in TTA All patients have bedside lockers links with self-administration Impact on Medicines review: - Accurate info. on administration for prescribing - Medicines available reduced missed doses
11 Patient s Own Drugs run chart:
12 Patient s Own Drugs savings: Patient Own Drugs Savings North Bristol NHS Trust Apr 1992 Mar 2014 Total Savings - 4, 800, /07 390,536 08/09 598,050 10/11 705, / , /93 05/06 359,408 07/ ,074 09/10 592,280 11/12 730,551 13/14 405,026
13 atients Own Drugs Poster:
14 Missed Doses Definition: Missed Doses are medication errors that occur when a medicine is not given to a patient when prescribed. They may cause harm to patients, lead to increased morbidity/mortality and inflate healthcare costs Causes: a result of errors during the supply, prescribing, dispensing or administration of medicines in hospitals and in patients home. Impact on Medicines review: - To consider impact when reviewing prescribing
15 Missed Doses key drivers: NPSA alert (2010): RRR009: Reducing harm from omitted and delayed medicines in hospital NPSA/NICE: Medicines Reconciliation guidance (2007) Medication Safety Thermometer (2013) Medicines Optimisation Dashboard (2014)
16 Missed Doses actions: Phase 1 (Pre 2014 MOVE ): A training package and Laminated posters An e-audit tool Ward handover sheets Pink missed dose order slip/orange leaflet Focus group discussion Phase 2 (Post MOVE ): Missed Doses Dashboard Admissions Medical Unit (AMU) audit Medication Safety Alert poster
17 Missed Doses Medication Safety Alert poster
18 Missed Doses run chart:
19 Missed Doses Dashboard
20 Warfarin key drivers: Warfarin is a high risk medicine. Patients with INR>6 are at exponentially increasing risk of bleeding. Drivers include: NPSA alert (2007) Actions that make anticoagulation safer. SPI2 set a target of reducing harm from anticoagulants by monitoring INRs>6. Impact on Medicines review: - Accurate info. on administration for prescribing - Potential drug interactions
21 Warfarin actions: Re-design the warfarin administration chart: highlighting co-prescribing of interacting medication adding prescribing hints removing 10mg doses from low loading regimen updating management of high INRs and bleeding Development of the mini-rca tool Medical and nursing electronic learning packages Medication Safety Alert
22 Warfarin run chart:
23 Warfarin origin of INR >6:
24 Warfarin causes:
25 Role of MSO National scene: England NPSA (National Patient Safety Agency)- now NHS Improvement National Alerts : Actions - Three-stage alerting system - new Patient Safety Alerts (PSA s): Stage 1: - Warning action required in approx. 1 month Stage 2: - Resources action required in approx. 3 months Stage 3: - Directive action required in approx. 6 months Regional Networks steal shamelessly!! Impact on Medicines review: high risk drugs e.g. fatalities from missed desmopressin
26 NHS Medication Safety
27 NHS Medication Safety
28 NHS MSO role Organisation count NHS Acute Medium 46 NHS Acute Large 41 NHS Acute Teaching 30 NHS Acute Small 24 NHS Acute Specialist 17 count aggregat e NHS Acute Trust 158 CCG 80 NHS Mental Health Trust 51 Community pharmacy sector 21 Other Independent Sector 21 NHS Community Trusts 18 NHS England Area Team 14 NHS Ambulance Trust 9 Community Interest Company 8 Independent 2 Cosmetic Surgery 1 Mental Health 1 NHS Acute 1 Online Pharmacy 1 Social Care Enterprise 1 Grand Total 387
29 NHS MSO impact and role
30 NHS MSO impact and role
31 Role of MSO NBT actions: Medication Safety Subgroup Nurse / Doctor / Patient / Risk manager / MSO Incidents reports Numbers of reports causing harm : Total number of reports Actions internal alerts / SOPs / safety work streams Work through Medicines Governance Group RCAs pharmacy input For all serious incidents externally reported
32 How are we sharing? Presentations and Workshops European Association of Hospital Pharmacists (EAHP) Academy Seminar Zagreb (September 2015) EAHP Congress, Hamburg (March 2015) West of England Academic Health Science Network Annual Conference (October 2014) National Pharmacy Management Forum (London: Nov 2013 and Nov 2014)
33 Achievements UK Awards: Shortlisted HSJ Value Awards (2016) I love my Pharmacist!! (2015) Pharmaceutical Care Awards (2015) HSJ Awards (2014) HQIP Awards (2014) LEAN Healthcare Academy Awards (2014) HSJ Patient Safety Award (2013) APTUK Awards (2014) - Winner Clinical Pharmacy Congress (2014) Winner
34 Key Learning points SPI2 - support from experts/peers - improvement methodology; learn from others ; share success and steal shamelessly!! Continuous Measurement is ESSENTIAL In God we Trust all others bring data! Buy-in of staff // start with enthusiasts // leave laggards. Tempting to spread too quickly. Plan, continue to embed and gain support as the project evolves.
35 SUMMARY QUESTIONS: Linked with the learning Objectives for today: Missed Doses impact on the outcome of Medicines Reconciliation and Medication review. True or false? Patients Own Drugs (in the UK) are a useful source for aiding Medicines Reconciliation and Medication review. True or false? The incidence of high INRs do not impact on Medication review. True or false?
36 Thank you - Any Questions? Jane.smith@nbt.nhs.uk
EAHP ACADEMY SEMINAR September 2015 from Medicines Reconciliation to Medicines Optimisation
EAHP ACADEMY SEMINAR 11-13 September 2015 from Medicines Reconciliation to Medicines Optimisation Jane Smith, Principal Pharmacist, Development & Governance NBT Medication Safety Officer (MSO) Disclosure
Reducing Medication Errors: National Update
Reducing Medication Errors: National Update Ahmed Ameer Medication Safety Officer Ahmed.Ameer@NHS.net Safer Medication Practice & Medical Devices Team 27 th January 2015 Agenda 1. Development of the National
Moving the Green Medicines Bag from the Safety Agenda to QIPP
Moving the Green Medicines Bag from the Safety Agenda to QIPP Jane Hough (ESEE Specialist Pharmacy Services) Fiona Eccleston (PSF Project Manager) Ed England ( Ambulance Service) Facts and figures 97%
Safe medication practice what can we learn from root cause analysis and related methods?
Safe medication practice what can we learn from root cause analysis and related methods? Dr David Gerrett, Senior Pharmacist Patient Safety NHS Improvement Information Day on Medication Errors 20 October
Pharmacy Technician led model to reduce the rate of omitted medicines
Pharmacy Technician led model to reduce the rate of omitted medicines By Fleur Baylis Lead Pharmacist Patient Safety Brighton and Sussex University Hospitals NHS Trust Outline NPSA alert Missed doses Trust
Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS
Safer use of anticoagulants: the NPSA patient safety alert Steve Chaplin MSc, MRPharmS Steve Chaplin describes the NPSA s anticoagulant patient safety alert and the measures it recommends for making the
Safety in Mental Health Collaborative
NHS Tayside Safety in Mental Health Collaborative Improving Safety in Mental Health Programme Aims supported by an Improvement Advisor: Dr Noeleen Devaney Support 4 UK organisations to: reduce harm improving
Medicines Reconciliation: Standard Operating Procedure
Clinical Medicines Reconciliation: Standard Operating Procedure Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation
Medicines Management Strategy
Medicines Management Strategy 2012 2014 Directorate responsible for the strategy: Medical and Governance Directorate Staff group to whom it applies: All clinical staff and Trust managers Issue date: 30/6/12
Improving compliance with oral methotrexate guidelines. Action for the NHS
Patient safety alert 13 Alert Immediate action Action Update Information request Ref: NPSA/2006/13 Improving compliance with oral methotrexate guidelines Oral methotrexate is a safe and effective medication
SPSP Medicines. Prepared by: NHS Ayrshire and Arran
SPSP Medicines Prepared by: NHS Ayrshire and Arran Medication Reconciliation: Story so far MR happening in primary care, acute adult, paediatrics and mental health Started in acute then mental health,
Medicines Use and Safety Annual Report The first stop for professional medicines advice. MUS Annual Report vs2 CL 1
Medicines Use and Safety Annual Report -17 The first stop for professional medicines advice www.sps.nhs.uk MUS Annual Report -17 vs2 CL 1 The Medicines Use and Safety (MUS) Team are part of the NHS Specialist
Introducing the NTDA. Medicines Optimisation and Pharmaceutical Services. Richard Seal Chief Pharmacist NHS Trust Development Authority
Introducing the NTDA Medicines Optimisation and Pharmaceutical Services Richard Seal Chief Pharmacist NHS Trust Development Authority What are the basic functions of the NHS TDA? Functions previously
Reconciliation of Medicines on Admission to Hospital
Reconciliation of Medicines on Admission to Hospital Policy Title State previous title where relevant. State if Policy New or Revised Policy Strand Org, HR, Clinical, H&S, Infection Control, Finance For
Introduction of EPMA in paediatric practice in UK:
Introduction of EPMA in paediatric practice in UK: REALISING THE CLINICAL BENEFITS AND ENGAGING CLINICAL STAFF Stephen Marks Consultant Paediatric Nephrologist and EPMA lead Great Ormond Street Hospital
Pharmaceutical Services Report to Joint Conference Committee September 2010
Pharmaceutical Services Report to Joint Conference Committee September 21 Background: Pharmaceutical Services staffing has increased by 31 FTE from 26 due to program changes and to comply with regulatory
Clinical. Prescribing Medicines SOP. Document Control Summary. Contents
Clinical Prescribing Medicines SOP Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation Date: Review Date: Key
Electronic Prescribing Medicine Administration (epma)
Electronic Prescribing Medicine Administration (epma) Christine Walters Director of IM&T The Pennine Acute Hospitals NHS Trust 10 th July 2013 How to get IM&T to be seen as a benefit not just a cost Example
My role as a Medication Safety Officer (MSO) Joanna Taylor, Lead Pharmacist Medication Safety, Risk and Compliance
My role as a Medication Safety Officer (MSO) Joanna Taylor, Lead Pharmacist Medication Safety, Risk and Compliance Overview CNWL Trust in context Implementing NHS England PSA - improving medication incident
Storyboard Submission NHS Wales Awards Title Improving Patient Safety How ABHB Ward Pharmacists Monitor Elevated INRs
Storyboard Submission 1. Title Improving Patient Safety How ABHB Ward Pharmacists Monitor Elevated 2. Brief Outline of Context As part of the 1000 Lives Plus initiative, ward pharmacists throughout ABHB
Tess Fenn. President APTUK
Tess Fenn President APTUK RPS: Pharmacy Workforce Summit Right place, right time, right number: positioning the workforce for patients Thursday 12th January 2017 Leading pharmacy technicians to deliver
UHNS Hospital Pharmacy Service and Hot Topics. Sue Thomson Clinical Director of Pharmacy and Medicines Optimisation
UHNS Hospital Pharmacy Service and Hot Topics Sue Thomson Clinical Director of Pharmacy and Medicines Optimisation 1,200 beds Cancer Centre status Trauma Centre Cystic Fibrosis centre Tertiary referral
UKMi and Medicines Optimisation in England A Consultation
UKMi and Medicines Optimisation in England A Consultation Executive Summary Medicines optimisation is an approach that seeks to maximise the beneficial clinical outcomes for patients from medicines with
Developing seven day services in hospital pharmacy: giving patients the care they deserve
Developing seven day services in hospital pharmacy: giving patients the care they deserve Dr Catherine Duggan, FRPharmS RPS Director of Professional Development and Support Why seven day services? Why
NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST MEDICINES CODE OF PRACTICE MEDICINES MANAGEMENT WHEN PATIENTS ARE DISCHARGED FROM HOSPITAL
NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST MEDICINES CODE OF PRACTICE MEDICINES MANAGEMENT WHEN PATIENTS ARE DISCHARGED FROM HOSPITAL Reference CL/MM/024 Date approved 13 Approving Body Directors Group
Oxfordshire Anticoagulation Service. Important information about anticoagulation with vitamin K antagonists Information for patients
Oxfordshire Anticoagulation Service Important information about anticoagulation with vitamin K antagonists Information for patients Page 2 Your information Name:... Address:......... or patient stickie
South Staffordshire and Shropshire Healthcare NHS Foundation Trust
South Staffordshire and Shropshire Healthcare NHS Foundation Trust Document Version Control Document Type and Title: Authorised Document Folder: Policy for Medicines Reconciliation on Admission and on
Pharmacological Therapy Practice Guidance Note Medicine Reconciliation on Admission to Hospital for Adults in all Clinical Areas within NTW V02
Pharmacological Therapy Practice Guidance Note Medicine Reconciliation on Admission to Hospital for Adults in all Clinical Areas within NTW V02 V02 issued Issue 1 May 11 Issue 2 Dec 11 Planned review May
Alert. Patient safety alert. Actions that can make anticoagulant therapy safer. 28 March Action for the NHS and the independent sector
Patient safety alert 18 Alert 28 March 2007 Immediate action Action Update Information request Ref: NPSA/2007/18 Actions that can make anticoagulant therapy safer Anticoagulants are one of the classes
Executive Summary points to consider by organisations providing Primary and Community Health services
pecialist Pharmacy ervice Medicines Use and afety A ummary of Pharmacy upport required to deliver Medicines Optimisation in Primary Care based and Community Health ervices: A guide for Organisational Boards
Medicines Management Accredited Programme (MMAP) N. Ireland
N. Ireland Medicines Welcome to the Northern Ireland Centre for Pharmacy Learning and Development (NICPLD) Medicines for pharmacy technicians practising in the secondary care sector in N. Ireland. The
Medicines Optimisation Patient Safety And Medication Safety. Dr David Cousins Associate Director Medication Safety and Medical Devices
Medicines Optimisation Patient Safety And Medication Safety Dr David Cousins Associate Director Medication Safety and Medical Devices The key elements of medicines optimisation is patient centred; makes
Supporting self-administration of medication in the care home setting
B143. November 2016 2.0 Community Interest Company Supporting self-administration of medication in the care home setting Care home residents should have the opportunity to make informed decisions about
Best Practice Guidelines - BPG 9 Managing Medicines in Care Homes
Best Practice Guidelines - BPG 9 Managing Medicines in Care Homes Medicines in Care Homes 1 DOCUMENT STATUS: Approved DATE ISSUED: 10 th November 2015 DATE TO BE REVIEWED: 10 th November 2017 AMENDMENT
How Pharmacies are supporting the move from Secondary to Primary Care. Peter Bainbridge, Director of Pharmacy,
How Pharmacies are supporting the move from Secondary to Primary Care Peter Bainbridge, Director of Pharmacy, Alliance Boots Present in over 25 countries Over 116,000 employees 3,330 Health and Beauty
MEDICINES RECONCILIATION GUIDELINE Document Reference
MEDICINES RECONCILIATION GUIDELINE Document Reference G358 Version Number 1.01 Author/Lead Job Title Jackie Stark Principle Pharmacist Clinical Services Date last reviewed, (this version) 29 November 2012
Quality Improvement Scorecard June 2017
Mortality: HSMR Nat NB: Each month is a 12 month rolling value. I.e. Mar-16 reports the monthly average of Apr-15 to Mar-16. Performance remained below target in February. Mortality: HSMR (weekday) vs.
Self-Administration Guidelines
SH CP 168 Self-Administration Guidelines Summary: Keywords (minimum of 5): (To assist policy search engine) Target Audience: Procedure for when a patient takes responsibility for taking own medicines as
This controlled document shall not be copied in part or whole without the express permission of the author or the author s representative.
This document is also available in large print and other formats and languages, upon request. Please call NHS Grampian Corporate Communications on (01224) 551116 or (01224) 552245. This controlled document
Improving Safety Practices Anticoagulation Therapy
Improving Safety Practices Anticoagulation Therapy Katie Cinnamon, PharmD, BCPS Clinical Pharmacist Genesis Medical Center - Davenport Objectives Review background information on medication errors and
BOARD CLINICAL GOVERNANCE & QUALITY UPDATE MARCH 2013
Borders NHS Board BOARD CLINICAL GOVERNANCE & QUALITY UPDATE MARCH 2013 Aim The aim of this report is to provide the Board with an overview of progress in the areas of: Patient Safety Person Centred Health
Medication Reconciliation
Medication Reconciliation Where are we now? Angie Powell, PharmD Director of Pharmacy Baxter Regional Medical Center Disclosures I, Angie Powell, have no relevant financial relationships to disclose. Learning
TRUST BOARD SAFETY AND QUALITY MONTHLY REPORT SEPTEMBER 2013
TRUST BOARD SAFETY AND QUALITY MONTHLY REPORT SEPTEMBER 2013 1. EXECUTIVE SUMMARY As reported to the Board last month, the reporting on safety and quality to the Trust Board has changed. Each month a summary
Northern Health - Acute Services. Evidence Based Practice Venous Thromboembolism Prevention
Northern Health - Acute Services Evidence Based Practice Venous Thromboembolism Prevention (VTE) Jeannette Kamar Christine Lamotte, Liam Carter Improving Patient Safety Preventing and Managing Venous Thromboembolism
Reducing Medication Errors
Reducing Medication Errors 1 st July 2015 Dr David Gerrett Senior Pharmacist April 2015 Patient Safety NHS E Manchester MCC Content 1. The Pharmacovigilance landscape 2. MSOs 3. What we know of error from
Meet the Pharmacy Team Experts in Medicine. Pharmacy Department
Meet the Pharmacy Team Experts in Medicine Pharmacy Department 01625 661266 Leaflet Ref: 15033 Published: 03/16 Review: 03/19 Page 1 Our role on the ward Your ward based pharmacy team consists of a pharmacist
Welcome & Introductions The Core Programme Overview. Dr Paul Ryan Clinical Director, North East Sector, Glasgow City CHP
Welcome & Introductions The Core Programme Overview Dr Paul Ryan Clinical Director, North East Sector, Glasgow City CHP House Keeping No Fire Alarm scheduled Toilets are located round to the right, past
All Wales Multidisciplinary Medicines Reconciliation Policy
All Wales Multidisciplinary Medicines Reconciliation Policy June 2017 This document has been prepared by the Quality and Patient Safety Delivery Group of the All Wales Chief Pharmacists Group, with support
Provide Safe and Effective Medicines Management in Primary Care
Primary Drivers Secondary Drivers Aim Safe and reliable prescribing, monitoring and administration of high risk medications that require systematic monitoring Implement systems for reliable prescribing
Kate Beaumont. Strategy Advisor, NPSA Head of Clinical Interventions, National Patient Safety Campaign.
Why Safety Matters Kate Beaumont Strategy Advisor, NPSA Head of Clinical Interventions, National Patient Safety Campaign Catherine.beaumont@npsa.nhs.uk www.npsa.nhs.uk About the NPSA What we are: Arm s
Policy for Self Administration of Medicine on Solent NHS Trust Inpatient Wards
Policy for Self Administration of Medicine on Solent NHS Trust Inpatient Wards Solent NHS Trust policies can only be considered to be valid and up-to-date if viewed on the intranet. Please visit the intranet
South West Accuracy Checking Pharmacy Technician Scheme
South West Medicines Information & Training South West Accuracy Checking Pharmacy Technician Scheme Transfer of Accreditation Toolkit South West Medicines Information & Training Bristol Royal Infirmary
Management of Reported Medication Errors Policy
Management of Reported Medication Errors Policy Approved By: Policy & Guideline Committee Date of Original 6 October 2008 Approval: Trust Reference: B45/2008 Version: 4 Supersedes: 3 February 2015 Trust
FT Keogh Plans. Medway NHS Foundation Trust
FT Keogh Plans Medway NHS Foundation Trust July 2014 KEY Delivered On Track to deliver Some issues narrative disclosure Not on track to deliver Medway - Our improvement plan & our progress What are we
Understanding Self Care for Life
NHS England s Chief Nursing Officer Julia Cummings blogged about Self Care Week More than 200 organisations took part in Self Care Week which was promoted through conferences, blogs, e-newsletters, websites,
Ensuring our safeguarding arrangements act to help and protect adults PRACTICE GUIDANCE FOR REPORTING MEDICATION INCIDENTS INTO SAFEGUARDING
Ensuring our safeguarding arrangements act to help and protect adults PRACTICE GUIDANCE FOR REPORTING MEDICATION INCIDENTS INTO SAFEGUARDING Contents Page 1.0 Purpose 2 2.0 Definition of medication error
Population. 4.1 million People Maori 14% Pacific People 6% Asian 6% 39.9 million sheep
Population 4.1 million People Maori 14% Pacific People 6% Asian 6% 39.9 million sheep Paul Cressey The New Zealand Health System New Zealand Health Information emedicine NZ Context Safe Medication Management
Our pharmacist led care home service
Our pharmacist led care home service Optimising the medicines of patients who are living in a care home. Suppor t Prescribing Ser vices Commissioning a care home medication review service (PSS) is one
Quality and Efficiency Support Team (QuEST) Directorate for Health Workforce and Performance
Quality and Efficiency Support Team (QuEST) Directorate for Health Workforce and Performance A Whole System Approach to Patient Flow for Scotland Our Quality Improvement Approach Jane Murkin Programme
Strategic overview: NHS system
Strategic overview: NHS system Dr Keith Ridge, Chief Pharmaceutical Officer 1 November 2016 A collaborative approach Five Year Forward View Oct 2014 NHS planning guidance, Dec 2015: Every health and care
Disclosure statement
Seminar T5 Novel ways of dispensing drugs Standardization & Centralization: The Right Way Forward András Vermes, PharmD, PhD EAHP 2016 Vienna, Austria Disclosure statement Conflict of interest: nothing
The Hospital Transfer Pathway. The Red Bag Initiative: Guide to Implementation
` The Hospital Transfer Pathway The Red Bag Initiative: Guide to Implementation Foreword The Health Innovation Network, the Academic Health Science Network for South London is working with Boroughs across
Hospital Pharmacy Transformation Plan
Hospital Pharmacy Transformation Plan Introduction In June 2014, Lord Carter of Coles was appointed to the position of Chair of a new NHS Procurement & Efficiency Board to direct the NHS Procurement &
MERSEY CARE NHS TRUST HOW WE MANAGE MEDICINES. What we do to check the accuracy of inpatient prescription charts. MM04
MERSEY CARE NHS TRUST HOW WE MANAGE MEDICINES Medicines Management Services aim to ensure that (i) Service users receive their medicines at times that they need them and in a safe way. (ii) Information
MMPR034 MEDICINES RECONCILIATION ON ADMISSION TO HOSPITAL PROTOCOL
MMPR034 MEDICINES RECONCILIATION ON ADMISSION TO HOSPITAL PROTOCOL 1 Table of Contents Why we need this Protocol...3 What the Protocol is trying to do...3 Which stakeholders have been involved in the creation
Information shared between healthcare providers when a patient moves between sectors is often incomplete and not shared in timely enough fashion.
THE DISCHARGE MEDICINES REVIEW SERVICE Introduction During a stay in hospital a patient s medicines may be changed. Studies show that many patients may experience an error or problem with their medicines
MANAGING THE INR CLINIC : IJN EXPERIENCE
MANAGING THE INR CLINIC : IJN EXPERIENCE Anticoagulation Workshop 21 st August 2015 KAMALESWARY ARUMUGAM PRINCIPAL PHARMACIST LEE LEE HO1 NURSE MENTOR, INR CLINIC HISTORY & OVERVIEW OF THE INR CLINIC HISTORY
Lewisham Integrated Medicines Optimisation Service
Lewisham Integrated Medicines Optimisation Service By Kath Howes (CCG) & Kay Fahy (University Hospital Lewisham) Katherine.howes@nhs.net LIMOS: 02030493228 Seen this before??- Hoarding & Wastage The Story
Setting up the NOAC Service & Taking it to Primary Care
Setting up the NOAC Service & Taking it to Primary Care Satinder Bhandal Consultant Anticoagulation Pharmacist November 2015 Buckinghamshire Health Care NHS Trust Quiz 1. What is the most serious side
Medicines optimisation in care homes
Medicines optimisation in care homes Programme overview March 2018 NHS England INFORMATION READER BOX Directorate Medical Operations and Information Specialised Commissioning Nursing Trans. & Corp. Ops.
Transforming Care in the NHS through Digital Technology
Transforming Care in the NHS through Digital Technology Paul Rice PhD Head of Technology Strategy NHS England 13 th April, 2015 DISCLAIMER: The views and opinions expressed in this presentation are those
YORKSHIRE AND HUMBER CLINICAL PHARMACY BENCHMARKING
YORKSHIRE AND HUMBER CLINICAL PHARMACY BENCHMARKING Chris Acomb BSc MPharm FRPharmS Clinical Pharmacy Manager (Professional Development) Leeds Teaching Hospitals With thanks to all my fellow Clinical Pharmacy
Foundation Pharmacy Framework
Association of Pharmacy Technicians UK Foundation Pharmacy Framework A framework for professional development in foundation across pharmacy APTUK Foundation Pharmacy Framework The Professional Leadership
WEST OF ENGLAND ACADEMIC HEALTH SCIENCE NETWORK. Patient Safety Collaborative Annual Report 2016/17. Page 1 of 9
WEST OF ENGLAND ACADEMIC HEALTH SCIENCE NETWORK Patient Safety Collaborative Annual Report 2016/17 Page 1 of 9 Contents 1. Introduction 2. Context 3. Partnerships and Leadership 4. Highlights of our 2016/17
A Human Factors based analysis of a clinical Handover system in acute care setting
A Human Factors based analysis of a clinical Handover system in acute care setting Dr Srikanth Mada Consultant Endocrinologist www.cddft.nhs.uk Human Factors In health - 1: 10 patients suffer from preventable
Releasing Time to Care The Productive Ward Programme Proposed Implementation Paper March 23rd 2009
Releasing Time to Care The Productive Ward Programme Proposed Implementation Paper March 23rd 2009 1 CONTENTS TABLE PAGE Page 2 Page 3 Page 4 Page 6 CONTENT Contents Page Introduction & Background Benefits
Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1
Managing medicines in care homes Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).
Medicines Reconciliation Policy
Medicines Reconciliation Policy Lead executive Medical Director Authors details Senior Clinical Pharmacy Technician - 01244 39 7494 Document level: Trustwide (TW) Code: MP19 Issue number: 3 Type of document
Sutton Homes of Care Vanguard Programme
Sutton Homes of Care Vanguard Programme An Innovative End of Life Care model for care homes Kings Fund Conference 6 th December 2016 Corinne Campion, Clinical Nurse Specialist, Supportive Care Home Team
Thoracic surgery medicines
Addressograph Name: Date of birth: Hosp No: NHS No: Thoracic surgery medicines A patient s guide Medicine name Date last dose to be taken 1 Introduction This booklet is for patients waiting to have thoracic
Pharmacy Technician s in the District Nursing Service. An insight into our role. Kieran Casey-McEvoy Senior Pharmacy Technician
Pharmacy Technician s in the District Nursing Service An insight into our role Kieran Casey-McEvoy Senior Pharmacy Technician District Nursing Service Visit housebound patients in Islington & Haringey.
MEDICINES POLICY. All staff working within the Trust who are involved in any way with the use of medicines. This includes locum and agency staff.
MEDICINES POLICY To be read in conjunction with: Antimicrobial Prescribing Policy; Clozapine Policy, Controlled Drugs Policy (see also section 28.2), and Medical Gases Policy. Version: 10 Date issued:
Improving patient safety through education and training - Report by the Commission on Education and Training for Patient Safety
Education and Training Committee, 9 June 2016 Improving patient safety through education and training - Report by the Commission on Education and Training for Patient Safety Executive summary and recommendations
Reducing errors with epma electronic Prescribing and Medicines Administration. Stockport NHS Foundation Trust December 2013
Reducing errors with epma electronic Prescribing and Medicines Administration Stockport NHS Foundation Trust December 2013 Introductions Helen Bennett Asst Director: IT Programme Mangement Sarah Campbell
Improving Diabetes Management in Care Homes within Swale CCG
Improving Diabetes Management in Care Homes within Swale CCG An Education Model to support Unregistered Practitioners in Diabetes Care and Delegation of Insulin Administration June 2016 Authors: Sarah
How to Report Medication Safety Incidents from a GP Practice on the National Reporting and Learning System (NRLS)
pecialist Pharmacy ervice Medicines Use and afety How to Report Medication afety Incidents from a GP Practice on the National Reporting and Learning ystem (NRL) This document provides a quick explanation
Influence of Patient Flow on Quality Care
Influence of Patient Flow on Quality Care Patients Waiting on Trolleys for an Inpatient Bed Patients who are Medically Fit to be discharged and cared for at Home with Support or in a Nursing Home or District
Report to the Trust Board
Report to the Trust Board Southport & Ormskirk Hospital NHS Trust Date of Board Meeting 26 January 2011 AGENDA ITEM: 7c Title of Report EXECUTIVE SUMMARY of the REPORT (please outline the purpose of this
TECHNICAL PHARMACY CURRICULUM GUIDE 2011/12
School of Pharmacy, University of London Postgraduate Diploma in General Pharmacy Practice TECHNICAL PHARMACY CURRICULUM GUIDE 2011/12 In association with the Joint Programmes Board: East and South East
South East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide
South East London Interface Prescribing Policy including the NHS and Private Interface Prescribing Guide 1. Introduction 1.1 This policy has been developed by the South East London Clinical Commissioning
NPSA Alert 03: Reducing the harm caused by oral Methotrexate. Implementation Progress Report July Learning and Sharing
NPSA Alert 03: Reducing the harm caused by oral Methotrexate Implementation Progress Report July 2006 Learning and Sharing CONTENTS Page 1 Background 3 2 Findings 4 Appendix 1 Summary of responses 6 Appendix
NATIONAL PATIENT SAFETY AGENCY DRAFT PATIENT SAFETY ALERT. Safer Use of Injectable Medicines In Near-Patient Areas
NATIONAL PATIENT SAFETY AGENCY DRAFT PATIENT SAFETY ALERT Safer Use of Injectable Medicines In Near-Patient Areas Wide Stake Holder Consultation January March 2006 The NPSA is undertaking a wide stake
Acute Medical Unit (AMU)
Acute Medical Unit (AMU) Contents What is the Acute Medical Unit? 3 What happens when I come to the unit? 3 What if I need to stay in the unit? 4 What if I need to be admitted to hospital? 5 What happens
Lithium: Policy for the Safe Initiation, Prescribing, Dispensing and Monitoring of Lithium Preparations. Version No 2.2.
Livewell Southwest Lithium: Policy for the Safe Initiation, Prescribing, Dispensing and Monitoring of Lithium Preparations Version No 2.2 Review: May 2019 Notice to staff using a paper copy of this guidance
When Medications Hurt: Preventing Adverse Drug Events. Plan for today.
When Medications Hurt: Preventing Adverse Drug Events Rachel Crowe, MPH, BSN, RN Danielle Watford, CMQ OE, MS Patient Safety Academy September 8, 2016 This material was prepared by Healthcentric Advisors,
Framework: Making the best use of medicines across all care settings
Framework: Making the best use of medicines across all care settings Introduction We know from the Care Homes Use of Medicines Study (CHUMS) report that medicines use in care homes needs to be challenged
Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) NHS Standard Contract Service Profile Pack ( )
Anti-Coagulation Monitoring (warfarin, acenocoumarol, phenindione) Primary Care Service (PCS:01) This pack contains: Standard Contract Service Profile Pack () 1. Service Specification: (to be inserted
HIQA s Medication Safety Monitoring Programme in Public Acute Hospitals. One Year Later
HIQA s Medication Safety Monitoring Programme in Public Acute Hospitals One Year Later Sean Egan Head of Healthcare Regulation Health Information and Quality Authority Presentation outline Recap on the
Clinical Check of Prescriptions in Ward Areas
Pharmacy Department Standard Operating Procedures SOP Title Clinical Check of Prescriptions in Ward Areas Author name and Gareth Price designation: Deputy Director of Pharmacy Clinical Services Pharmacy
Mental Health Pharmacist Education. Medication Reconciliation Patient Safety Initiative
Mental Health Pharmacist Education Medication Reconciliation Patient Safety Initiative August 2015 Introductions Agenda MedRec Project Overview Project Structure Implementation/Dates MedRec Basics What